Biểu đồ giá cổ phiếu VRAX
VRAX Thu nhập
Virax Biolabs Group Ltd
$2.86
1.41%
$0.04
Khi đóng cửa: Aug 14, 16:00:00 GMT-4
$2.8
-2.09%
$-0.06
Phiên sau giờ: Aug 14, 20:00:00 GMT-4
Quay lại
Virax Biolabs Group Ltd (VRAX) Thu nhập
Thống kê chính
Giá đóng cửa trước
$2.82
Giá mở cửa
$2.84
Phạm vi ngày
$2.78 - $2.86
Phạm vi 52 tuần
$2.5 - $27.5
Khối lượng
50.7K
Khối lượng trung bình
1.8M
Tỷ suất cổ tức
--
EPS (TTM)
-1.25
Vốn hóa thị trường
$55.7M
VRAX là gì?
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The firm is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The firm is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
